Zhejiang Shapuaisi Pharmaceutical Co Ltd (603168) — Cash Flow Reinvestment Rate
Zhejiang Shapuaisi Pharmaceutical Co Ltd (603168) has a Cash Flow Reinvestment Rate of 4.07x as of September 2025, reinvesting CN¥34.84 Million (capex CN¥34.84 Million ) from operating cash flow of CN¥8.57 Million. Check how high is Zhejiang Shapuaisi Pharmaceutical Co Ltd's earnings quality to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Zhejiang Shapuaisi Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (2008–2024)
Historical reinvestment intensity for Zhejiang Shapuaisi Pharmaceutical Co Ltd across 17 annual periods. Explore Zhejiang Shapuaisi Pharmaceutical Co Ltd debt service capacity to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Zhejiang Shapuaisi Pharmaceutical Co Ltd (2008–2024)
Year-by-year capital reinvestment analysis for Zhejiang Shapuaisi Pharmaceutical Co Ltd. For live market cap and broader valuation context, see Zhejiang Shapuaisi Pharmaceutical Co Ltd stock valuation.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 7.90x | CN¥202.80 Million | CN¥25.67 Million | CN¥128.11 Million | ▲ +4.2% |
| 2023 | 7.58x | CN¥314.65 Million | CN¥41.49 Million | CN¥219.80 Million | ▲ +354.4% |
| 2022 | 1.67x | CN¥193.13 Million | CN¥115.72 Million | CN¥148.69 Million | ▼ -62.5% |
| 2021 | 4.45x | CN¥448.68 Million | CN¥100.78 Million | CN¥153.44 Million | ▲ +46.6% |
| 2020 | 3.04x | CN¥133.91 Million | CN¥44.09 Million | CN¥17.18 Million | ▲ +566.2% |
| 2019 | 0.46x | CN¥27.11 Million | CN¥59.47 Million | CN¥20.33 Million | ▼ -87.4% |
| 2018 | 3.62x | CN¥363.80 Million | CN¥100.37 Million | CN¥58.38 Million | ▼ -15.1% |
| 2017 | 4.27x | CN¥194.50 Million | CN¥45.57 Million | CN¥114.00 Million | ▲ +281.3% |
| 2016 | 1.12x | CN¥329.44 Million | CN¥294.33 Million | CN¥39.94 Million | ▼ -28.1% |
| 2015 | 1.56x | CN¥177.94 Million | CN¥114.27 Million | CN¥97.94 Million | ▲ +124.8% |
| 2014 | 0.69x | CN¥102.53 Million | CN¥147.99 Million | CN¥102.53 Million | ▲ +13.8% |
| 2013 | 0.61x | CN¥71.73 Million | CN¥117.86 Million | CN¥71.73 Million | ▼ -43.1% |
| 2012 | 1.07x | CN¥71.91 Million | CN¥67.27 Million | CN¥71.91 Million | ▼ -45.3% |
| 2011 | 1.95x | CN¥29.59 Million | CN¥15.14 Million | CN¥29.59 Million | ▲ +326.0% |
| 2010 | 0.46x | CN¥8.06 Million | CN¥17.57 Million | CN¥8.06 Million | ▲ +56.1% |
| 2009 | 0.29x | CN¥8.49 Million | CN¥28.87 Million | CN¥8.49 Million | ▼ -74.7% |
| 2008 | 1.16x | CN¥13.01 Million | CN¥11.20 Million | CN¥13.01 Million | — |